Adicet Bio, Inc. - Common Stock (NQ:ACET)

6.500 -0.140 (-2.11%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 04, 2024

Via Benzinga

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024

January 04, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook

January 03, 2024

From Adicet Bio, Inc.

Via Business Wire

Wedbush Maintains Outperform Rating for Adicet Bio: Here's What You Need To Know ↗

November 09, 2023

Via Benzinga

6 Analysts Have This to Say About Adicet Bio ↗

June 27, 2023

Via Benzinga

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

December 29, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting

December 10, 2023

From Adicet Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 08, 2023

Via Benzinga

Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach ↗

November 27, 2023

Why Are Gamma-Delta T Cells Important In Fighting Cancer?

Via Benzinga

Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates

November 08, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference

November 07, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting

November 02, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

October 31, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference

October 04, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

September 29, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

September 27, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

August 31, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates

August 09, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference

August 02, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

July 31, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Announces Appointment of Katie Peng to the Board of Directors

July 11, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 30, 2023

From Adicet Bio, Inc.

Via Business Wire

Analyst Downgrades Adicet Citing Uncertainty, Awaits Long-Term Data On Durability ↗

June 27, 2023

JMP Securities downgraded Adicet Bio Inc (NASDAQ: ACET) to a Market Perform (from Market Outperform) and removed the

Via Benzinga

Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results ↗

June 27, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

Dow Up Triple Digits As Consumer Confidence Increases ↗

June 27, 2023

Stocks are on the rise this afternoon.

Via Talk Markets

Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 27, 2023

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.

Via Benzinga

Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast ↗

June 27, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023 ↗

June 27, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.